摘要
Annual unpredictable efficacy of vaccines, coupled with emerging drug resistance, underlines the development of new antiviral drugs to treat influenza infections. The N-terminal domain of the PA (PA(N)) endonuclease is both highly conserved across influenza strains and serotypes and is indispensable for the viral lifecycle, making it an attractive target for new antiviral therapies. Here, we describe the discovery of a new class of PA(N) inhibitors derived from recently identified, highly active hits for PA(N) endonuclease inhibition. By use of structure-guided design and systematic SAR exploration, the hits were elaborated through a fragment growing strategy, giving rise to a series of 1, 3-cis-2-substituted-1-(3, 4-dihydroxybenzyl)-6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline-3-carboxylic acid derivatives as potent PAN inhibitors. This approach ultimately resulted in the development of a new lead compound 13e, which exhibited an EC50 value of 4.50 mu M against H1N1 influenza virus in MDCK cells.
学科与关键词
- Identification of N- and C-3-Modified Laudanosoline Derivatives as Novel Influenza PAN Endonuclease InhibitorsLiao, Yixian; Ye, Yilu; Liu, Mingjian; Liu, Zhihao; Wang, Jinshen; Li, Baixi; Huo, Lijian; Zhuang, Yilian; Chen, Liye; Chen, Jianxin; Gao, Yongfeng; Ning, Xiaoyun; Li, Sumei*; Liu, Shuwen*; Song, Gaopeng*Journal of Medicinal Chemistry, 2023, 66(1): 188-219.被引 3
- Emerging and state of the art hemagglutinin-targeted influenza virus inhibitors.Zhang, Qiao; Liang, Taizhen; Nandakumar, Kutty Selva; Liu, Shuwen*EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22(6): 715-728.被引 15
- Screening and identification of 3-aryl-quinolin-2-one derivatives as antiviral agents against influenza ACheng, Huimin; Fu, Liangbing*; Yang, Xia; Yang, Yujian; Zhang, Zhening; Tao, Yuan; Wan, Junting; Tu, Zhengchao; Chen, Jianxin*; Li, Yingjun*Journal of Medical Virology, 2023, 95(1): e28327.
